CIK 0001372514
- Non-accelerated filer
- Smaller reporting company
KIORA PHARMACEUTICALS INC
Sign in to watch- Tickers
- KPRX KPHMW
- Exchange
- Nasdaq, OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 980443284
- Phone
- +1 858-224-9600
- Business address
- 169 SAXONY RD., SUITE 212, ENCINITAS, CA, 92024
- Former names
- EYEGATE PHARMACEUTICALS INC
Securities
- KPRX Common Stock Nasdaq
- KPHMW Common stock OTC
- 4 Shares withheld for taxes VP of Research & Development gave up 97 shares (to pay taxes)
- 4 Shares withheld for taxes VP of Engineering gave up 97 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Financial Officer gave up 97 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Financial Officer gave up 95 shares (to pay taxes)
- 4 Shares withheld for taxes President and CEO gave up 615 shares (to pay taxes)
- 4 Shares withheld for taxes VP of Engineering gave up 95 shares (to pay taxes)
- 4 Shares withheld for taxes VP of Research & Development gave up 92 shares (to pay taxes)
- 4 Shares withheld for taxes President and CEO gave up 625 shares (to pay taxes)
- 4 Shares withheld for taxes VP of Engineering gave up 97 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Financial Officer gave up 97 shares (to pay taxes)
- 4 Shares withheld for taxes VP of Research & Development gave up 94 shares (to pay taxes)
- 4 Shares withheld for taxes President and CEO gave up 627 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Financial Officer gave up 94 shares (to pay taxes)
- 4 Shares withheld for taxes VP of Research & Development gave up 94 shares (to pay taxes)
- 4 Shares withheld for taxes VP of Engineering gave up 94 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Financial Officer gave up 93 shares (to pay taxes)
- 4 Shares withheld for taxes VP of Research & Development gave up 113 shares (to pay taxes)
- 4 Shares withheld for taxes VP of Engineering gave up 93 shares (to pay taxes)
- 4 Shares withheld for taxes President and CEO gave up 617 shares (to pay taxes)
- 4 Shares withheld for taxes VP of Research & Development gave up 122 shares (to pay taxes)
Page 9 of 21 · 406 filings